期刊文献+

Med19基因敲减增加乳腺癌细胞化疗敏感性及其可能的机制 被引量:7

Med19 knockdown promotes chemosensitivity of breast cancer cells and its possible mechanism
下载PDF
导出
摘要 目的:研究中介体(mediator,Med)19对乳腺癌化疗敏感性的影响并分析其分子机制。方法:选用多柔比星(adriamycin,ADM)耐药的人乳腺癌细胞MCF-7/ADM和亲本细胞MCF-7(NC组),采用慢病毒载体介导RNA干扰方法构建Med19稳定低表达的MCF-7/ADM与MCF-7细胞株(KD组),并用Real-time PCR和Western blotting方法验证干扰效果。CCK-8法检测慢病毒介导的Med19敲减前后两种细胞对ADM、顺铂(cisplatin,DDP)和紫杉醇(taxinol,TAX)药物敏感性的变化。Real-time PCR和Western blotting检测Med19敲减对多药耐药基因1(multidrug resistance 1,MDR1)和细胞凋亡基因Bcl2、Bax及Caspase-3、active Caspase-3的表达的影响。流式细胞术检测敲减Med19及ADM处理对细胞凋亡的影响。结果:与MCF-7相比,MCF-7/ADM细胞对ADM、DDP和TAX均具有耐药性。成功构建Med19稳定低表达的MCF-7/ADM与MCF-7细胞株,并且其对ADM、DDP、TAX的敏感性增加,药物作用IC_(50)显著降低(均P<0.05)。MCF-7/ADM细胞Med19 mRNA和蛋白表达显著高于MCF-7细胞,Med19的敲减可降低MCF-7/ADM细胞中MDR1 mRNA与蛋白表达水平(均P<0.05)并可增加MCF-7/ADM及MCF-7细胞中凋亡相关active Caspase-3、Bax的蛋白表达,降低Bcl2的蛋白表达(均P<0.05)。此外,与NC及NC+ADM组相比,KD组及KD+ADM组凋亡水平显著增加(均P<0.05)。结论:Med19高表达参与乳腺癌化疗耐药,其机制可能与Med19调节MDR1的表达并影响细胞凋亡有关。 Objective:To explore the effect and molecular mechanism of mediator 19 (Med19) on drug sensitivity of breast cancer cells. Methods: Human breast cancer cell line MCF-7/ADM (adriamycin resistant) and it’s parental cell line MCF-7(NC groups) were selected. Lentivirus-mediated RNA-interference was used to construct MCF-7/ADM and MCF-7 cell lines that stably expressing low Med19(KD groups), and the infection efficiency was detected by Real-time PCR and Western blotting assays. The change of drug-susceptibility to ADM, cisplatin (DDP) and taxinol (TAX) were examined with CCK-8 assay before and after Med19 knockdown. The effects of Med19 knockdown on the expressions of multidrug resistance gene 1(MDR1), Bcl2, Bax,Caspase-3 and active caspase-3 in breast cancer cells were detected by RT-PCR and Western Blotting assays, respectively. Effect of Med19 down-regulation and ADM treatment on apoptosis rates of MCF-7 and MCF-7/ADM cells were detected with flow cytometry assay. Results: Compared with MCF-7 cells, MCF-7/ADM cells exhibited drug resistance to ADM, DDP and TAX. MCF-7/ADM and MCF-7 cell lines that stably expressing low Med19level were successfully established; their drug-susceptibilities to ADM, DDP, TAX were increased, and the IC50 values of these three cytotoxic agents deceased obviously (all P〈0.05). The mRNA and protein expressions of Med19in MCF-7/ADM cells were significantly higher than those in MCF-7 cells, however, Med19knockdown significantly inhibited the expressions of MDR1mRNA and protein in MCF-7/ADM cells (all P〈0.05); in addition, it significantly increased the expressions of active caspase-3 and Bax protein in both MCF-7/ADM and MCF-7 cells (all P〈0.05) and decreased the expression of Bcl2 protein (all P〈0.05). Besides, compared with NC or NC+ADM group, the apoptosis rate of the cells significantly increased in KD group or KD+ADM group (all P〈0.05). Conclusions: High Med19expression plays a particularly important role in chemoresistance of breast cancer, and the mechanism might correlate with Med19regulating MDR1 expression and affecting apoptosis related genes.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2017年第4期380-388,共9页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金面上项目资助(No.81472485) 无锡市卫计委资助项目(No.Q201615 YGZXM14038No.YGZXQ1311)~~
关键词 中介体19 乳腺癌 多药耐药 多柔比星 mediator19 breast cancer multidrug resistance adriamycin
  • 相关文献

参考文献4

二级参考文献31

  • 1耿长新,曾昭冲,周长宏,王吉耀,亓玉琴.多烯紫杉醇体内对肝癌放化疗及其对p21和bcl-2表达影响[J].世界华人消化杂志,2005,13(24):2848-2852. 被引量:9
  • 2Li L H, He J, Hua D, et al. Lentivirus-mediated inhibition ofMedl9 suppresses growth of breast cancer cells in vitro [J]. Cancer Chemoth Pharm, 2010,Oct 2. [Epub ahead of print ].
  • 3Takagi Y, Kornberg R D. Mediator as a general transcription factor [J]. J Biol Chem, 2006,281(1):80-89.
  • 4Singh H, Erkine A M, Kremer S B, et al. A iunctional module of yeast mediator that governs the dynamic range of heat-shock gene expression [J]. Genetics, 2006,172(4) :2169-2184.
  • 5B6ve J, Hu G Z, Myers L C, et al, The structural and functional role of Med5 in the yeast Mediator tail module [J]. J Biol Chem, 2005,280 (4) : 1366-1372.
  • 6Baidoobonso S M, Guidi B W, Myers L C. Medl9(Rox3) regulates Intermodule interactions in the Saccharomyces cerevisiae mediator complex [ J ]. J Biol Chem, 2007,282 (8) : 5551-5559.
  • 7Uprichard S L. The therapeutic potential of RNA intertfrence [J]. FEBS Lett, 2005,579(26) :5996-6007.
  • 8McIntyre G J, Groneman J L, Yu Y H, et al. Multiple shRNA combinations for near-complete coverage of all HIV-I strains [J]. AIDS ResTher, 2011,8(1):1-15.
  • 9Shaobin Wu,Xianwei Wang,Jinxiang Chen,Yuxiang Chen.Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells[J]. Biochemical and Biophysical Research Communications . 2013 (4)
  • 10Barboule N,Chadebech P,Baldin V,et al.Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncegene . 1997

共引文献7

同被引文献56

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部